There are concerns recently arising from how medications associated with diabetes is being regulated. According to an investigation made by the British Medical Journal, the system used in regulating, evaluating and promoting diabetes medications worldwide may be up for further review. According to BMJ Editor-In-Chief Dr. Fiona Godlee, medications for diabetes such as the top-selling drug rosiglitazone, more comm